Sauce Labs launches 'programmable infrastructure' for mobile testing with Real Device Access API - SiliconANGLE ...
Sauce Labs today announced general availability of the Real Device Access API, giving developers a programmable mobile testing infrastructure that offers device-level controls with no testing ...
Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. Nvidia is expanding physical AI through new partnerships in lab robotics and ...
Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. Danaher (NYSE:DHR) has ...
PLEASANTON, Calif., Feb. 9, 2026 /PRNewswire/ -- Unchained Labs, the life sciences company that's all about getting researchers the right tool for the job, launched Stuntman today, a next-generation ...
LONDON, Feb. 5, 2026 /PRNewswire/ -- EX3, a strategic SAP partner and global provider of payroll and HR solutions, today announced the launch of EX3 AI Labs, a dedicated innovation hub designed to ...
Labroots is delighted to host the 10th Annual Event in the Laboratory Automation Virtual Event Series, scheduled on March 18th, 2026! Dive into the cutting edge of laboratory technology at this free ...
Integrating AI with advanced robotics to create self-driving labs (SDL) is a promising approach to tackling molecular discovery. A new SDL system, called LUMI-lab, combines large-scale molecular ...
“We’re currently renting a tiny portion of a stone fabricator’s workshop,” says Micah Springut, the founder of New York–based start-up Monumental Labs. “But this is about 37,000 square feet,” he adds, ...
QIAGEN Showcases QIAsprint Connect High-Throughput Automation System for Labs Worldwide at SLAS 2026
QIAsprint Connect marks entry into high-throughput sample processing, enabling labs to scale workflows with flexible protocols, compact design and sustainability-focused features QIAGEN also to ...
Today, laboratories around the world are under greater pressure to deliver accurate results while also dealing with more stringent regulations, increased workflow complexity, and a serious shortage of ...
Modern biotech has the tools to edit genes and design drugs, yet thousands of rare diseases remain untreated. According to executives from Insilico Medicine and GenEditBio, the missing ingredient for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results